Pages that link to "Q61648255"
Jump to navigation
Jump to search
The following pages link to SLCO1B1 gene variability influences lipid-lowering efficacy on simvastatin therapy in Southern Brazilians (Q61648255):
Displaying 12 items.
- Candidate-Gene Study of Functional Polymorphisms in SLCO1B1 and CYP3A4/5 and the Cholesterol-Lowering Response to Simvastatin (Q33648028) (← links)
- Evaluation of sexual dimorphism in the efficacy and safety of simvastatin/atorvastatin therapy in a southern Brazilian cohort (Q34020658) (← links)
- Meta-Analysis of the SLCO1B1 c.521T>C Variant Reveals Slight Influence on the Lipid-Lowering Efficacy of Statins (Q35332088) (← links)
- Individual and Combined Associations of Genetic Variants in CYP3A4, CYP3A5, and SLCO1B1 With Simvastatin and Simvastatin Acid Plasma Concentrations (Q35855012) (← links)
- SLCO1B1 c.388A>G Polymorphism Is Associated with HDL-C Levels in Response to Atorvastatin in Chilean Individuals. (Q36184009) (← links)
- The frequency of SLCO1B1*5 polymorphism genotypes among Russian and Sakha (Yakutia) patients with hypercholesterolemia (Q36956524) (← links)
- Interindividual variability in hepatic organic anion-transporting polypeptides and P-glycoprotein (ABCB1) protein expression: quantification by liquid chromatography tandem mass spectroscopy and influence of genotype, age, and sex (Q37422685) (← links)
- Ontogeny of Hepatic Drug Transporters as Quantified by LC-MS/MS Proteomics (Q39683666) (← links)
- SLCO1A2, SLCO1B1 and SLCO2B1 polymorphisms influences chloroquine and primaquine treatment in Plasmodium vivax malaria. (Q41911842) (← links)
- No impact of SLCO1B1 521T>C, 388A>G and 411G>A polymorphisms on response to statin therapy in the Greek population. (Q54216256) (← links)
- Associations of the SLCO1B1 Polymorphisms With Hepatic Function, Baseline Lipid Levels, and Lipid-lowering Response to Simvastatin in Patients With Hyperlipidemia (Q58863415) (← links)
- ESR1 polymorphisms and statin therapy: a sex-specific approach (Q61648202) (← links)